Register for real-time alerts, custom portfolio, and market movers
Period:
Draw Mode:
| Volume | 825,231 |
|
|||||
| News | - | ||||||
| Day High | 2.38 | Low High |
|||||
| Day Low | 2.14 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Lyell Immunopharma Inc | LYEL | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| 0.16 | 7.37% | 2.33 | 18:21:19 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 2.18 | 2.14 | 2.38 | 2.33 | 2.17 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 6,740 | 825,231 | $ 2.29 | $ 1,889,029 | - | 1.32 - 3.97 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 18:21:18 | 1 | $ 2.22 | USD |
Lyell Immunopharma Inc Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 589.5M | 254.10M | - | 2.92M | -234.63M | -0.92 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Lyell Immunopharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical LYEL Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.42 | 2.48 | 2.11 | 2.23 | 525,992 | -0.09 | -3.72% |
| 1 Month | 2.04 | 3.145 | 2.015 | 2.44 | 928,308 | 0.29 | 14.22% |
| 3 Months | 1.87 | 3.2556 | 1.69 | 2.31 | 912,266 | 0.46 | 24.60% |
| 6 Months | 1.66 | 3.2556 | 1.52 | 2.11 | 1,128,722 | 0.67 | 40.36% |
| 1 Year | 2.01 | 3.97 | 1.32 | 2.31 | 1,016,439 | 0.32 | 15.92% |
| 3 Years | 18.75 | 19.84 | 1.32 | 4.80 | 938,984 | -16.42 | -87.57% |
| 5 Years | 18.75 | 19.84 | 1.32 | 4.80 | 938,984 | -16.42 | -87.57% |
Lyell Immunopharma Description
| Lyell Immunopharma Inc is a T cell reprogramming company dedicated towards the mastery of T cells to eradicate solid tumors. Its pipeline includes CARs (Chimeric antigen receptors), TILs (Tumor-infiltrating lymphocytes), and TCRs (T cell receptors). |
